TLX 1.18% $20.98 telix pharmaceuticals limited

AFR- China’s Grand Decade drops 73 m Telix stakes

  1. 98 Posts.
    lightbulb Created with Sketch. 36
    Aug 11, 2022 – 5.11pm

    Save

    Share
    JPMorgan’s equities desk is seeking buyers about a 3 per cent stake in ASX-listed Telix Pharmaceuticals on Thursday evening.


    The broker launched the block trade after market, seeking bids from $7.25 to $7.40 a share.

    The deal was priced at a 10.3 per cent discount at the floor price, and 8.4 per cent at the ceiling.

    The trade was worth $73 million at the floor price.

    The seller was disclosed as Grand Decade Developments Limited, which had about a 7.6 per cent stake prior to Thursday’s block trade.


    Grand Decade Developments is part of China Grand Pharmaceutical and Healthcare Holdings Ltd.

    The stake represented half of Grand Decade’s shares in the ASX-listed Telix. The rest would be put into a voluntary lockup, according to terms sent to potential buyers.

    JPMorgan’s desk was seeking bids by Thursday nigh
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.